A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.
Jacob TF, Singh V, Dixit M, Ginsburg-Shmuel T, Fonseca B, Pintor J, Youdim MBH, Major DT, Weinreb O, Fischer B.
Jacob TF, et al. Among authors: singh v.
Purinergic Signal. 2018 Sep;14(3):271-284. doi: 10.1007/s11302-018-9614-7. Epub 2018 Jul 17.
Purinergic Signal. 2018.
PMID: 30019187
Free PMC article.